BostonGene Competitors and Similar CompaniesClear all

QuellTX's competitors and similar companies include ExeVir Bio and Talaris Therapeutics.
QuellTX
QuellTX
QuellTX is a company that develops T-regulatory cell therapies.
ExeVir Bio
ExeVir Bio
ExeVir Bio is a company that harnesses a llama-derived antibody technology platform to generate antiviral therapies providing broad protection against coronaviruses.
Talaris Therapeutics
Talaris Therapeutics
Talaris Therapeutics is a cell therapy company developing an method of allogeneic hematopoietic stem cell transplantation.
Founding Date
Founding Date
2019
Founding Date
2020
Founding Date
2002
Type
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
London, GB HQ
London, GB
Locations
Gent, BE HQ
Locations
Wellesley, US HQ
Houston, US
Louisville, US
Louisville, US
Louisville, US
Employees
Employees
1534% decrease
Employees
1611% decrease
Employees
82

Funding

Latest funding round
Latest funding round
$ 44.5m (about 7 years ago)
Latest funding round
$ 23m (about 5 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 44.5m
Total funding raised
$ 50m
Total funding raised
$ 215m
For sources of this data, please see the company profile

View Company Profiles

ExeVir Bio
HQ
Gent, BE
Employees
16↓ 11% decrease

ExeVir Bio is a company that harnesses a llama-derived antibody technology platform to generate antiviral therapies providing broad protection against coronaviruses.

View company
Talaris Therapeutics
HQ
Wellesley, US
Employees
82

Talaris Therapeutics is a cell therapy company developing an method of allogeneic hematopoietic stem cell transplantation.

View company